Beijing Scitop Bio-tech Future Growth
Future criteria checks 5/6
Beijing Scitop Bio-tech is forecast to grow earnings and revenue by 33.3% and 31% per annum respectively while EPS is expected to grow by 34.4% per annum.
Key information
33.3%
Earnings growth rate
34.4%
EPS growth rate
Food earnings growth | 31.2% |
Revenue growth rate | 31.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 05 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 504 | 166 | N/A | 138 | 1 |
12/31/2024 | 403 | 123 | N/A | 108 | 1 |
3/31/2024 | 286 | 92 | -88 | 113 | N/A |
12/31/2023 | 299 | 93 | -71 | 107 | N/A |
9/30/2023 | 322 | 95 | -64 | 128 | N/A |
6/30/2023 | 352 | 105 | -37 | 113 | N/A |
3/31/2023 | 355 | 106 | 30 | 135 | N/A |
1/1/2023 | 369 | 110 | 64 | 148 | N/A |
9/30/2022 | 360 | 111 | 113 | 150 | N/A |
6/30/2022 | 354 | 110 | 144 | 173 | N/A |
3/31/2022 | 370 | 111 | 58 | 128 | N/A |
12/31/2021 | 365 | 110 | 43 | 110 | N/A |
9/30/2021 | 364 | 109 | 11 | 72 | N/A |
6/30/2021 | 366 | 103 | -1 | 59 | N/A |
3/31/2021 | 361 | 103 | 71 | 87 | N/A |
12/31/2020 | 339 | 97 | 45 | 67 | N/A |
9/30/2020 | 334 | 99 | 68 | 95 | N/A |
6/30/2020 | 313 | 92 | 42 | 80 | N/A |
3/31/2020 | 315 | 95 | 33 | 92 | N/A |
12/31/2019 | 308 | 93 | 52 | 98 | N/A |
6/30/2019 | 305 | 90 | 60 | 112 | N/A |
3/31/2019 | 296 | 84 | 22 | 84 | N/A |
1/1/2019 | 318 | 92 | -6 | 90 | N/A |
12/31/2017 | 284 | 71 | N/A | 84 | N/A |
12/31/2016 | 261 | 12 | N/A | 33 | N/A |
12/31/2015 | 185 | 35 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300858's forecast earnings growth (33.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 300858's earnings (33.3% per year) are forecast to grow faster than the CN market (22.7% per year).
High Growth Earnings: 300858's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300858's revenue (31% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 300858's revenue (31% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300858's Return on Equity is forecast to be high in 3 years time